Rahim, N. (2025). Bispecific CAR-T vs. BCMA-Specific CAR-T: Advancing Treatment for Relapsed/Refractory Multiple Myeloma. Highlights in Science, Engineering and Technology, 153, 42-47. https://doi.org/10.54097/wvmnsh51